Interview by SCMP

Updated: Apr 19

“Providing rapid diagnosis to ensures doctors or disease control organizations can respond by making swift and effective healthcare decisions” has always been the core value of Sanwa BioTech. This has stand true especially in the COVID-19 pandemic as we demonstrate to the public through our interview with South China Morning Post on how the team at Sanwa had been working around the clock to provide ALiA platform as a diagnostic device to help people battle the deadly coronavirus disease and improve general health.


0 views0 comments

Recent Posts

See All

SIHHK Press Conference

Since its outbreak in December 2019, the COVID-19 pandemic had created despair in the society and a significant change in the society. In view of this, the Society for Innovative Healthcare Hong Kong

GIES 2020

Gerontech and innovation expo cum summit (GIES) is an exhibition which jointly hosted by HKSAR government and Hong Kong Council of social service, and co-organized with Hong Kong Science and Technolog

Clinical trial in HKU

ALiA SARS-CoV-2 Antigen FIA Test is a rapid microfluidic-based fluorescent immunoassay test for qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral antigens fro